Aaron Bloomer, Chief Financial Officer of ResMed Inc., filed a Form 4 on November 13, 2026, reporting a disposition of 1,095.137 shares of ResMed common stock on November 11, 2026, for tax withholding purposes related to a vesting restricted stock unit award.
Key Highlights
- Reporting person: Aaron Bloomer, Chief Financial Officer of ResMed Inc. (NYSE:RMD)
- Transaction date: November 11, 2026
- Shares disposed: 1,095.137 shares of ResMed common stock, coded "F" (disposition to issuer for tax withholding)
- Price per share: $234.11
- Remaining beneficial ownership: 7,977 shares held directly following the transaction
- Source of disposition: Tax withholding on vesting of Restricted Stock Units granted on June 1, 2026
Bloomer's RSU Vesting and Tax Withholding Transaction at ResMed
According to the filing, Aaron Bloomer, in his capacity as Chief Financial Officer of ResMed Inc., reported a single non-derivative transaction on November 11, 2026. The transaction involved the disposition of 1,095.137 shares of ResMed common stock at a price of $234.11 per share. The filing designates this transaction with code "F," indicating a disposition to the issuer for the purpose of satisfying tax withholding obligations.
The filing states in its explanation of responses that the disposition was made "to issuer for tax withholding on vesting of Restricted Stock Units granted on 6/1/2026." This type of transaction reflects a standard mechanism in which a company withholds a portion of shares upon RSU vesting to cover the reporting person's tax liability, rather than a discretionary open-market sale. Following the reported transaction, the filing indicates Bloomer directly held 7,977 shares of ResMed common stock.
The Form 4 was filed on November 13, 2026, with Bloomer's signature. No derivative securities transactions were reported, and Table II of the filing contains no entries. The filing was made by one reporting person and does not indicate that any amendment to a prior filing was involved.
What Was Disclosed
ResMed CFO Aaron Bloomer disclosed the disposition of 1,095.137 shares of ResMed common stock at $234.11 per share on November 11, 2026, solely for tax withholding on RSUs granted June 1, 2026, leaving him with 7,977 directly held shares.



Please wait processing your request...